Interactive Web Sites Hold High Risk For Marketing Non-Compliance
Executive Summary
Drug companies must stay on their toes to deal with the marketing compliance issues that can arise when using interactive social networking sites to promote their products, marketing experts warn
You may also be interested in...
Who's Liable For Online Content? Pharma, Marketers Disagree (Slightly)
Compensation and collaboration - as well as creation - should be the triggers for determining a pharmaceutical company's liability for Internet content, Rohit Bhargava of Ogilvy 360 Digital Influence advised FDA during a Nov. 12-13 hearing on promoting medical products on the Internet and in social media
Who's Liable For Online Content? Pharma, Marketers Disagree (Slightly)
Compensation and collaboration - as well as creation - should be the triggers for determining a pharmaceutical company's liability for Internet content, Rohit Bhargava of Ogilvy 360 Digital Influence advised FDA during a Nov. 12-13 hearing on promoting medical products on the Internet and in social media
DDMAC 2.0: FDA To Host November Meeting On Web And New Media Promotion
Advertising rules for search engines, YouTube and blogs are among the topics for the two-day meeting.